Nonalcoholic fatty liver disease is a serious health condition in overweight children which can lead to heart disease. This project will examine the links between liver health and cardiovascular risk factors in overweight and obese children, and will test the effect of a long-term after-school exercise program. Provision of comprehensive evidence for the benefits of exercise on children's health may reduce barriers to vigorous physical activity programs during a childhood obesity epidemic.
This is an ancillary study adding cardiometabolic outcome measures to an ongoing NIH-funded randomized trial of exercise in overweight children ("SMART study," R01 HL087923, P.I. Davis, NCT02227095). This presents the opportunity to obtain detailed measures of liver and vascular health to provide information about the effects of exercise on these conditions.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
175
Heart rate monitors worn by each child at each session
Supervised recreational program with token economy
Georgia Prevention Institute
Augusta, Georgia, United States
Change in Liver Fat
Change in the proportion of liver fat via MRI
Time frame: Baseline, 8 Months
Change in Arterial Stiffness
Change in carotid-femoral pulse wave velocity
Time frame: Baseline, 8 Months
Change in Liver Fibrosis
Change in Fibroscan transient elastography measure
Time frame: Baseline, 8 Months
Change in Liver Inflammation
Change in ratio of aspartate aminotransferase to alanine aminotransferase (AST/ALT), C-reactive protein
Time frame: Baseline, 8 Months
Change in Quality of Life
Change in PedsQL questionnaire responses
Time frame: Baseline, 8 Months
Associations among Liver Fat, Fibrosis and Inflammation, Arterial Stiffness, and Other Cardiovascular Risk Indices
At baseline, the proportion of liver fat (ascertained by MRI) will be closely related to indices of liver fibrosis (as detected by transient elastography) and inflammation (ratio of aspartate aminotransferase to alanine aminotransferase, AST/ALT; C-reactive protein, CRP), and to arterial stiffness and other indices of cardiovascular risk (body fat (DXA), visceral fat (MRI), aerobic fitness, insulin resistance, adiponectin, dyslipidemia).
Time frame: Baseline
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.